Publicacións (13) Publicacións nas que participase algún/ha investigador/a

filter_list Clinical Biochemistry

2024

  1. Carbohydrate antigen 125 on epicardial fat and its association with local inflammation and fibrosis-related markers

    Journal of Translational Medicine, Vol. 22, Núm. 1

2022

  1. Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 12

  2. Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models

    International Journal of Molecular Sciences, Vol. 23, Núm. 10

  3. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

    Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529

  4. The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

    Cells, Vol. 11, Núm. 8

2021

  1. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

    Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433

2020

  1. CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

    Frontiers in Physiology, Vol. 11

2016

  1. Protein Inhibitor of NOS1 Plays a Central Role in the Regulation of NOS1 Activity in Human Dilated Hearts

    Scientific Reports, Vol. 6

2015

  1. Key structural and functional differences between early and advanced glycation products

    Journal of Molecular Endocrinology, Vol. 56, Núm. 1, pp. 23-37

  2. The adipokine chemerin induces apoptosis in cardiomyocytes

    Cellular Physiology and Biochemistry, Vol. 37, Núm. 1, pp. 176-192

2014

  1. Heart mitochondrial proteome study elucidates changes in cardiac energy metabolism and antioxidant PRDX3 in human dilated cardiomyopathy

    PLoS ONE, Vol. 9, Núm. 11

  2. Impaired Adipogenesis and Insulin Resistance in Epicardial Fat-Mesenchymal Cells From Patients With Cardiovascular Disease

    Journal of Cellular Physiology, Vol. 229, Núm. 11, pp. 1722-1730

2011

  1. Aliskiren affects fatty-acid uptake and lipid-related genes in rodent and human cardiomyocytes

    Biochemical Pharmacology, Vol. 82, Núm. 5, pp. 491-504